Company news

InspireMD Inc. news in 2025

InspireMD Inc.'s news releases, calls and decks from 2025, newest first.

View company

Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting

November 24, 2025

InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

November 19, 2025

InspireMD Reports Third Quarter 2025 Financial Results

November 4, 2025

InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

November 3, 2025

InspireMD to Announce Third Quarter 2025 Financial Results

October 21, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

October 9, 2025

InspireMD Announces the Appointment of Dan Dearen to its Board of Directors

September 17, 2025

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

August 27, 2025

InspireMD Reports Second Quarter 2025 Financial Results

August 5, 2025

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors

July 31, 2025

InspireMD Announces Combined Financings of $58 Million

July 31, 2025

InspireMD to Announce Second Quarter 2025 Financial Results

July 22, 2025

InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke

July 9, 2025

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke

June 24, 2025

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

June 13, 2025

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

June 3, 2025

InspireMD Reports First Quarter 2025 Financial Results

May 9, 2025

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

April 30, 2025

InspireMD to Announce First Quarter 2025 Financial Results

April 25, 2025

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

March 26, 2025

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

March 12, 2025

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

February 26, 2025

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

February 12, 2025

Calls in 2025

Decks in 2025